ASIATODAY

BIZ&TECH

SK Biopharmaceuticals signs $4B AI drug discovery pact with Insilico

SK Biopharmaceuticals is stepping into central nervous system (CNS) drug discovery in partnership with Insilico Medicine, an AI-driven drug development company. Under the deal valued at up to approximately $4 billion, SK Biopharmaceuticals secures exclusive ownership and global commercialization rights for the newly discovered drug candidates. SK Biophar..

Chinese imports sold as ‘brands’ spark backlash on Ably
The long-standing controversy over so-called “label swapping” in the fashion distribution industry is now spreading to low- and mid-priced online fashion p..

OCI Holdings initiates major US ESS project, boosting North American power business

previous block

11 12 13 14 15 16 17 18 19 20

next block

Most Read

1

FBI foils terror plot against Trump’s White House..

2

Iran to allow IAEA inspectors back for uranium dis..

3

Japan, UK issue joint economic security declaratio..

4

Chinese tourists' resumption of travel to Japan fa..

5

US House approves $106 trillion for immigration, b..

6

Korea-Czech World Cup opener at 11 AM: live on Nav..

7

Trump mulls $300bn Iran rebuild fund with potentia..

PEOPLE

"Hallyu ban to be removed quickly": Hopes of thaw in Seoul-Beijing ties: · "Efforts will be made to remove Hallyu ban quickly"; · SK Group Chairman heads to Japan to soften "WD risk"

PHOTO

Jang Won-young shines as BVLGARI’s holiday muse

S.KOREA

POLITICS

SOCIAL AFFAIRS

WORLD

CHINA

INDIA

OTHERS

ECONOMY

BIZ&TECH

CULTURE

PEOPLE

PHOTO

Address : In-Young Bldg., 34, Uisadang-daero 1-gil, Yeongdeungpo-gu, Seoul

Copyright by ASIATODAY CO., LTD. All rights resereved